Cover Image
Market Research Report

Asia Pacific Biochips Market Forecast 2019-2028

Published by Inkwood Research Product code 603655
Published Content info 226 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Biochips Market Forecast 2019-2028
Published: May 18, 2020 Content info: 226 Pages
Description

KEY FINDINGS

The Asia Pacific biochips market is anticipated to record a CAGR of 14.06% over the projected period of 2019-2028. Rising awareness towards precision and personalized medicines, an increase in the number of various genome sequencing projects in the region, and an upsurge in the adoption rate of biochips in the healthcare industry, are promoting the market growth.

MARKET INSIGHTS

The Asia Pacific biochips market growth is further studied by segmenting the region into Japan, Thailand, India, Australia & New Zealand, South Korea, Indonesia, China, Vietnam, and the rest of Asia Pacific that includes Sri Lanka, Malaysia, Singapore, Taiwan, and Hong Kong among others. In Indonesia, the prevalence of chronic diseases and increased demand for quick and accurate diagnosis can be enabled by biochip technology. Pharmaceutical companies may increase R&D in this region in the future, which will supplement the market growth. Thailand, with its strategic location, superb infrastructure, and substantial scientific capability, is home to many well-established tech labs and pharma companies, and is ready to accept the new trend of advanced biotech development.

In countries like Vietnam, a continuous increase in healthcare spending, together with the necessary modernization of the healthcare system, is estimated to augment market growth. The government aims to provide 100% insurance coverage to the population by 2030. Such developments are creating opportunities for medical devices and pharmaceutical producers, which may benefit the market. In Australia, the government funded a considerable amount for the development of organ-on-chip technology. New Zealand has a strong biological sector, and the country can compete internationally in the area of lab-on-a-chip. In Malaysia, the biochip market growth is driven by considerable R&D activities in the field of nanotechnology.

COMPETITIVE INSIGHTS

Agilent Technologies, Inc, F. Hoffmann-La Roche Ltd, bioMerieux S.A., Bio-Rad Laboratories Inc, Illumina, Inc, etc. are some of the prominent companies operating in the region.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents
Product Code: 12920

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
  • 3.2. DEVELOPMENT OF BIOCHIPS
  • 3.3. MARKET DEFINITION
  • 3.4. KEY DRIVERS
    • 3.4.1. RISING INCIDENCES OF CHRONIC DISEASES
    • 3.4.2. GROWING INTEREST IN PERSONALIZED MEDICINES
    • 3.4.3. APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
    • 3.4.4. RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
  • 3.5. KEY RESTRAINTS
    • 3.5.1. HIGH INSTRUMENTATION COST
    • 3.5.2. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
    • 3.5.3. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
    • 3.5.4. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 3.5.5. LACK OF COMMON REGULATORY STANDARDS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON BIOCHIPS
  • 4.2. KEY INVESTMENT INSIGHTS
  • 4.3. PORTER'S FIVE FORCE ANALYSIS
    • 4.3.1. BUYER POWER
    • 4.3.2. SUPPLIER POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
    • 4.6.1. RESEARCH & DEVELOPMENT
    • 4.6.2. RAW MATERIALS
    • 4.6.3. MANUFACTURING
    • 4.6.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
    • 4.6.5. END-USER
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COST
    • 4.7.2. APPLICATIONS
    • 4.7.3. PRODUCT TYPE
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY TYPE

  • 5.1. DNA CHIPS
    • 5.1.1. AGRICULTURAL BIOTECHNOLOGY
    • 5.1.2. CANCER DIAGNOSIS & TREATMENT
    • 5.1.3. DRUG DISCOVERY
    • 5.1.4. GENE EXPRESSION
    • 5.1.5. GENOMICS
    • 5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
    • 5.1.7. OTHER DNA CHIPS
  • 5.2. LAB ON A CHIP
    • 5.2.1. CLINICAL DIAGNOSTICS
    • 5.2.2. DRUG DISCOVERY
    • 5.2.3. GENOMICS
    • 5.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
    • 5.2.5. PROTEOMICS
    • 5.2.6. OTHER LAB ON A CHIP
  • 5.3. PROTEIN CHIPS
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. DRUG DISCOVERY
    • 5.3.3. EXPRESSION PROFILING
    • 5.3.4. HIGH THROUGHPUT SCREENING
    • 5.3.5. PROTEOMICS
    • 5.3.6. OTHER PROTEIN CHIPS
  • 5.4. OTHER TYPES
    • 5.4.1. CELL ARRAYS
    • 5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS

  • 6.1. GLASS
  • 6.2. POLYMERS
  • 6.3. SILICON
  • 6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USER

  • 7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
  • 7.2. HOSPITALS AND DIAGNOSTICS CENTERS
  • 7.3. ACADEMIC AND RESEARCH INSTITUTES

8. GEOGRAPHICAL ANALYSIS

  • 8.1. ASIA PACIFIC
    • 8.1.1. CHINA
    • 8.1.2. JAPAN
    • 8.1.3. INDIA
    • 8.1.4. SOUTH KOREA
    • 8.1.5. INDONESIA
    • 8.1.6. THAILAND
    • 8.1.7. VIETNAM
    • 8.1.8. AUSTRALIA & NEW ZEALAND
    • 8.1.9. REST OF ASIA PACIFIC

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES INC
  • 9.2. AGILENT TECHNOLOGIES INC
  • 9.3. BIOCHAIN INSTITUTE INC
  • 9.4. BIOMERIEUX SA
  • 9.5. BIO-RAD LABORATORIES INC
  • 9.6. CEPHEID
  • 9.7. CYBRDI INC
  • 9.8. F HOFFMANN-LA ROCHE LTD
  • 9.9. FLUIDIGM CORPORATION
  • 9.10. GE HEALTHCARE
  • 9.11. ILLUMINA INC
  • 9.12. MERCK KGAA
  • 9.13. PERKINELMER INC
  • 9.14. RANDOX LABORATORIES LTD
  • 9.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BIOCHIPS
  • TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018
  • TABLE 3: REGULATORY FRAMEWORK
  • TABLE 4: ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
  • TABLE 15: ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: ASIA PACIFIC BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: ASIA PACIFIC BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: DEVELOPMENT OF BIOCHIPS
  • FIGURE 2: KEY INVESTMENT INSIGHTS
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: KEY BUYING CRITERIA
  • FIGURE 8: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019
  • FIGURE 9: ASIA PACIFIC BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019
  • FIGURE 11: ASIA PACIFIC BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: ASIA PACIFIC BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 14: ASIA PACIFIC BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 15: ASIA PACIFIC BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: ASIA PACIFIC BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 17: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: ASIA PACIFIC BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)
  • FIGURE 19: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019
  • FIGURE 20: ASIA PACIFIC BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: ASIA PACIFIC BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 22: ASIA PACIFIC BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 23: ASIA PACIFIC BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)
  • FIGURE 24: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)
  • FIGURE 26: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019
  • FIGURE 28: ASIA PACIFIC BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: ASIA PACIFIC BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 30: ASIA PACIFIC BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)
  • FIGURE 31: ASIA PACIFIC BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 32: ASIA PACIFIC BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)
  • FIGURE 35: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019
  • FIGURE 36: ASIA PACIFIC BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)
  • FIGURE 37: ASIA PACIFIC BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019
  • FIGURE 39: ASIA PACIFIC BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: ASIA PACIFIC BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)
  • FIGURE 41: ASIA PACIFIC BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)
  • FIGURE 42: ASIA PACIFIC BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)
  • FIGURE 43: ASIA PACIFIC BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 44: ASIA PACIFIC BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)
  • FIGURE 45: ASIA PACIFIC BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 46: ASIA PACIFIC BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
  • FIGURE 47: ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 48: CHINA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: JAPAN BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: INDIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 51: SOUTH KOREA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: INDONESIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 53: THAILAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 54: VIETNAM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 55: AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 56: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
Back to Top